HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ahmet Demirkazik Selected Research

MINE regimen

9/2010Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ahmet Demirkazik Research Topics

Disease

11Neoplasms (Cancer)
05/2021 - 10/2005
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 11/2004
3Lung Neoplasms (Lung Cancer)
05/2021 - 01/2013
3Neoplasm Metastasis (Metastasis)
01/2021 - 01/2002
3Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2009
3Breast Neoplasms (Breast Cancer)
06/2018 - 01/2002
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2019
1Renal Cell Carcinoma (Grawitz Tumor)
10/2019
1Arthralgia (Joint Pain)
01/2019
1Pleural Effusion (Pleural Effusions)
01/2019
1Dyspnea (Shortness of Breath)
01/2019
1Edema (Dropsy)
01/2019
1Capillary Leak Syndrome
01/2019
1Myalgia
01/2019
1Fever (Fevers)
01/2019
1Adenocarcinoma of Lung
05/2018
1Hypersensitivity (Allergy)
07/2017
1Cardiac Tamponade
07/2017
1Pericardial Effusion
07/2017
1Chronic Disease (Chronic Diseases)
04/2017
1Dermatitis
01/2012
1Osteosarcoma (Osteogenic Sarcoma)
01/2012
1Xeroderma Pigmentosum (Kaposi's Disease)
01/2012
1Adenocarcinoma
01/2012
1Mucositis
01/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2010
1Carcinogenesis
01/2009
1Brain Diseases (Brain Disorder)
06/2008
1Stroke (Strokes)
06/2008
1Nasopharyngeal Carcinoma
06/2008
1Brain Neoplasms (Brain Tumor)
06/2008
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2007
1Disease Progression
05/2007
1Malignant Mesothelioma
09/2006
1Venous Thromboembolism
10/2005
1Thrombosis (Thrombus)
10/2005
1Thromboembolism
10/2005
1Sarcoma (Soft Tissue Sarcoma)
12/2004

Drug/Important Bio-Agent (IBA)

3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 11/2004
3GemcitabineFDA Link
05/2007 - 12/2004
2Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2022 - 05/2018
2CytokinesIBA
01/2019 - 01/2002
2Biomarkers (Surrogate Marker)IBA
04/2017 - 06/2015
2ABO Blood-Group SystemIBA
01/2013 - 01/2012
2Blood Group Antigens (Blood Groups)IBA
01/2013 - 01/2012
2Fluorouracil (Carac)FDA LinkGeneric
01/2012 - 06/2004
2IfosfamideFDA LinkGeneric
09/2010 - 12/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2010 - 12/2004
2Cisplatin (Platino)FDA LinkGeneric
09/2006 - 06/2004
1Tyrosine Kinase InhibitorsIBA
04/2022
1AfatinibIBA
04/2022
1PlatinumIBA
05/2021
1OsteopontinIBA
01/2021
1SialoglycoproteinsIBA
01/2021
1Somatostatin Receptors (Somatostatin Receptor)IBA
10/2019
1gallium Ga 68 dotatateIBA
10/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1Interleukin-2 (IL2)IBA
01/2019
1Interleukin-11 (Interleukin 11)IBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Complement System Proteins (Complement)IBA
01/2019
1Vitamin DFDA LinkGeneric
06/2018
1ErbB Receptors (EGF Receptor)IBA
05/2018
1Docetaxel (Taxotere)FDA Link
07/2017
1LeptinIBA
04/2017
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
04/2017
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
04/2017
1Indicators and Reagents (Reagents)IBA
07/2015
1Rh-Hr Blood-Group System (Rhesus Blood-Group System)IBA
01/2013
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2012
1Methotrexate (Mexate)FDA LinkGeneric
01/2012
1Oxidoreductases (Dehydrogenase)IBA
01/2012
1AntimetabolitesIBA
01/2012
15' Untranslated Regions (5' UTR)IBA
01/2012
1Capecitabine (Xeloda)FDA Link
01/2012
1Rituximab (Mabthera)FDA Link
09/2010
1Mesna (Coenzyme M)FDA LinkGeneric
09/2010
1Etoposide (VP 16)FDA LinkGeneric
09/2010
1Prednisolone (Predate)FDA LinkGeneric
09/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2010
1Vincristine (Oncovin)FDA LinkGeneric
09/2010
1Mitoxantrone (Novantrone)FDA LinkGeneric
09/2010
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2009
1Proteins (Proteins, Gene)FDA Link
01/2009
1Nadroparin (Nadroparin Calcium)IBA
05/2007
1CalciumIBA
05/2007
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
05/2007
1Factor VIII (Coagulation Factor VIII)IBA
10/2005
1cancer procoagulantIBA
10/2005
1Thromboplastin (Tissue Factor)IBA
10/2005
1Oxygen (Dioxygen)IBA
10/2005
1ThrombinFDA Link
10/2005

Therapy/Procedure

5Drug Therapy (Chemotherapy)
05/2021 - 01/2002
4Therapeutics
05/2021 - 01/2002
2Radiotherapy
06/2008 - 01/2002
2Combination Drug Therapy (Combination Chemotherapy)
05/2007 - 12/2004
1Adjuvant Chemotherapy
05/2021
1MINE regimen
09/2010
1Central Venous Catheters
10/2005
1Salvage Therapy
12/2004